Systemic metabolic derangements in T2D has also been shown to activate NF-κB: hyperglycaemia-triggered activation of the PKC pathway via DAG, increased hexosamine pathway flux, increased AGEs, and increased polyol pathway flux (Du et al., 2003). Here, NFKB1 is linked to type 2 diabetes mellitus.